QIAGEN N.V.
QGEN
$45.42
-$0.18-0.40%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.04B | 2.00B | 1.98B | 1.97B | 1.94B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.04B | 2.00B | 1.98B | 1.97B | 1.94B |
| Cost of Revenue | 688.26M | 948.68M | 940.43M | 946.36M | 936.99M |
| Gross Profit | 1.35B | 1.05B | 1.04B | 1.02B | 1.00B |
| SG&A Expenses | 569.06M | 563.61M | 564.36M | 568.60M | 568.06M |
| Depreciation & Amortization | 61.81M | 64.62M | 68.14M | 71.55M | 74.24M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.50B | 1.76B | 1.77B | 1.78B | 1.77B |
| Operating Income | 536.36M | 240.02M | 211.79M | 188.81M | 166.58M |
| Income Before Tax | 488.68M | 138.41M | 121.15M | 114.17M | 97.55M |
| Income Tax Expenses | 115.29M | 44.73M | 37.56M | 21.24M | 24.85M |
| Earnings from Continuing Operations | 373.39 | 93.68 | 83.59 | 92.93 | 72.70 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 373.39M | 93.68M | 83.59M | 92.93M | 72.70M |
| EBIT | 536.36M | 240.02M | 211.79M | 188.81M | 166.58M |
| EBITDA | 712.29M | 419.87M | 402.06M | 386.39M | 364.74M |
| EPS Basic | 1.72 | 0.42 | 0.38 | 0.42 | 0.33 |
| Normalized Basic EPS | 1.61 | 0.76 | 0.68 | 0.62 | 0.56 |
| EPS Diluted | 1.70 | 0.41 | 0.37 | 0.41 | 0.32 |
| Normalized Diluted EPS | 1.61 | 0.75 | 0.67 | 0.62 | 0.55 |
| Average Basic Shares Outstanding | 869.23M | 868.35M | 867.59M | 867.18M | 866.31M |
| Average Diluted Shares Outstanding | 874.20M | 871.84M | 871.93M | 871.52M | 871.19M |
| Dividend Per Share | 0.25 | 0.25 | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |